Nosocomial , , , and : Sensitivity to Chlorhexidine-Based Biocides and Prevalence of Efflux Pump Genes.

Marina V Kuznetsova, Larisa Y Nesterova, Veronika S Mihailovskaya, Polina A Selivanova, Darja A Kochergina, Marina O Karipova, Igor V Valtsifer, Anastasia S Averkina, Marjanca Star��i�� Erjavec
Author Information
  1. Marina V Kuznetsova: Laboratory of Molecular Biotechnology, Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614081 Perm, Russia. ORCID
  2. Larisa Y Nesterova: Laboratory of Microorganisms' Adaptation, Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614081 Perm, Russia.
  3. Veronika S Mihailovskaya: Laboratory of Molecular Biotechnology, Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614081 Perm, Russia. ORCID
  4. Polina A Selivanova: Laboratory of Molecular Biotechnology, Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614081 Perm, Russia. ORCID
  5. Darja A Kochergina: Laboratory of Molecular Biotechnology, Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614081 Perm, Russia.
  6. Marina O Karipova: Department of Microbiology and Virology, Perm State Medical University Named After Academician E. A. Wagner, 614000 Perm, Russia.
  7. Igor V Valtsifer: Department of Multiphase Dispersed System, Institute of Technical Chemistry Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614013 Perm, Russia.
  8. Anastasia S Averkina: Department of Multiphase Dispersed System, Institute of Technical Chemistry Ural Branch Russian Academy of Sciences, Perm Federal Research Centre of Ural Branch of RAS, 614013 Perm, Russia.
  9. Marjanca Star��i�� Erjavec: Department of Microbiology, Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia. ORCID

Abstract

The widespread use of disinfectants and antiseptics has led to the emergence of nosocomial pathogens that are less sensitive to these agents, which in combination with multidrug resistance (MDR) can pose a significant epidemiologic risk. We investigated the susceptibility of nosocomial , , , and to a 0.05% chlorhexidine (CHX) solution and a biocidal S7 composite solution based on CHX (0.07%) and benzalkonium chloride (BAC, 0.055%). The prevalence of efflux pump genes associated with biocide resistance and their relationship to antibiotic resistance was also determined. Both biocides were more effective against Gram-positive than Gram-negative bacteria. The most resistant strains were strains, which were mainly killed by 0.0016% CHX and by 0.0000084% (CHX)/0.0000066% (BAC) S7. The S7 bactericidal effect was observed on and after 10 min, while the bactericidal effect of CHX was only observed after 30 min. and efflux pump genes were prevalent among and , while was more often detected in . , , , , and were prevalent in . The observed prevalence of efflux pump genes highlights the potential problem whereby the sensitivity of bacteria to biocides could decline rapidly in the future.

Keywords

References

  1. Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 1):535-40 [PMID: 23513610]
  2. Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0106921 [PMID: 34280018]
  3. J Clin Microbiol. 2006 Jun;44(6):2119-25 [PMID: 16757607]
  4. Antimicrob Agents Chemother. 2002 Jun;46(6):2024-8 [PMID: 12019132]
  5. J Arthroplasty. 2019 Jul;34(7S):S312-S318 [PMID: 30878506]
  6. J Hosp Infect. 2012 Jun;81(2):87-91 [PMID: 22498639]
  7. Drug Resist Updat. 2016 Sep;28:13-27 [PMID: 27620952]
  8. J Appl Microbiol. 2002;92 Suppl:65S-71S [PMID: 12000614]
  9. FEMS Immunol Med Microbiol. 2010 Aug;59(3):525-8 [PMID: 20602639]
  10. Jundishapur J Nat Pharm Prod. 2014 Apr 14;9(2):e14298 [PMID: 24872940]
  11. Cell Mol Biol (Noisy-le-grand). 2016 Aug 31;62(10):7-15 [PMID: 27609468]
  12. GMS Hyg Infect Control. 2013 Nov 06;8(2):Doc15 [PMID: 24327941]
  13. Environ Pollut. 2021 Aug 15;283:117074 [PMID: 33848900]
  14. J Bacteriol. 2012 Apr;194(7):1753-62 [PMID: 22267518]
  15. Healthcare (Basel). 2023 Jul 05;11(13): [PMID: 37444780]
  16. Microbiol Spectr. 2018 Apr;6(2): [PMID: 29676244]
  17. PLoS One. 2014 Jan 23;9(1):e86669 [PMID: 24466194]
  18. Ann Agric Environ Med. 2021 Sep 16;28(3):361-366 [PMID: 34558254]
  19. Microb Pathog. 2020 Feb;139:103850 [PMID: 31706002]
  20. Front Cell Infect Microbiol. 2024 Aug 15;14:1442914 [PMID: 39211793]
  21. Antimicrob Agents Chemother. 2010 Dec;54(12):5070-3 [PMID: 20855743]
  22. PLoS One. 2014 Jul 15;9(7):e101840 [PMID: 25025665]
  23. J Hosp Infect. 2007 May;66(1):93-5 [PMID: 17350728]
  24. Am J Infect Control. 2019 Jun;47S:A96-A105 [PMID: 31146858]
  25. Trop Med Infect Dis. 2023 May 12;8(5): [PMID: 37235321]
  26. Antimicrob Agents Chemother. 2010 Jan;54(1):177-83 [PMID: 19858254]
  27. Antimicrob Agents Chemother. 1998 Jan;42(1):65-71 [PMID: 9449262]
  28. Am J Infect Control. 2013 Dec;41(12):e119-22 [PMID: 23910527]
  29. Microb Drug Resist. 2019 Oct;25(8):1155-1163 [PMID: 31613200]
  30. Clin Microbiol Infect. 2012 Mar;18(3):268-81 [PMID: 21793988]
  31. Antibiotics (Basel). 2023 Apr 22;12(5): [PMID: 37237701]
  32. Iran J Basic Med Sci. 2022 Jun;25(6):775-780 [PMID: 35949304]
  33. Microorganisms. 2020 Oct 24;8(11): [PMID: 33114277]
  34. J Clin Microbiol. 2017 Jun;55(6):1857-1864 [PMID: 28381601]
  35. Antibiotics (Basel). 2022 May 30;11(6): [PMID: 35740143]
  36. Antimicrob Agents Chemother. 2014 Aug;58(8):4404-10 [PMID: 24841265]
  37. Mol Biol Rep. 2021 Jun;48(6):5275-5281 [PMID: 34245410]
  38. Antimicrob Agents Chemother. 2005 Jan;49(1):161-9 [PMID: 15616291]
  39. J Bacteriol. 1988 Dec;170(12):5416-22 [PMID: 2848006]
  40. Pathog Glob Health. 2015 Jun;109(4):184-92 [PMID: 26184804]
  41. Am J Infect Control. 2013 May;41(5 Suppl):S6-11 [PMID: 23622751]
  42. Eur J Pharm Sci. 2014 Dec 18;65:29-37 [PMID: 25218991]
  43. Open Microbiol J. 2017 Jun 30;11:132-141 [PMID: 28839493]
  44. Infect Immun. 2023 Dec 12;91(12):e0030323 [PMID: 37982617]
  45. Environ Pollut. 2018 May;236:734-744 [PMID: 29454283]
  46. Antibiotics (Basel). 2023 Feb 02;12(2): [PMID: 36830216]
  47. FEMS Microbiol Lett. 1998 Feb 15;159(2):173-8 [PMID: 9503610]
  48. BMC Infect Dis. 2020 Jan 30;20(1):88 [PMID: 32000698]
  49. J Bacteriol. 2010 May;192(10):2525-34 [PMID: 20233929]
  50. J Antimicrob Chemother. 2012 Jul;67(7):1655-9 [PMID: 22438434]
  51. Heliyon. 2024 Apr 27;10(9):e30464 [PMID: 38711646]
  52. Iran J Microbiol. 2023 Feb;15(1):27-37 [PMID: 37069917]
  53. Biol Pharm Bull. 2002 Dec;25(12):1533-6 [PMID: 12499635]
  54. Environ Sci Technol. 2017 Jan 3;51(1):570-580 [PMID: 27997135]
  55. FEMS Microbiol Lett. 2000 Feb 1;183(1):95-8 [PMID: 10650208]
  56. Mol Microbiol. 1989 Dec;3(12):1669-83 [PMID: 2560119]
  57. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20254-9 [PMID: 24277845]
  58. Antibiotics (Basel). 2022 Aug 09;11(8): [PMID: 36009947]
  59. J Hosp Infect. 2024 Sep;151:99-108 [PMID: 38992843]
  60. Clin Infect Dis. 2017 Oct 15;65(8):1412-1419 [PMID: 28520859]
  61. World J Microbiol Biotechnol. 2024 Jun 1;40(7):226 [PMID: 38822187]
  62. Antibiotics (Basel). 2020 Dec 09;9(12): [PMID: 33317032]
  63. Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):301-309 [PMID: 27764576]
  64. Int J Environ Res Public Health. 2021 Apr 06;18(7): [PMID: 33917580]
  65. PLoS One. 2017 Jun 6;12(6):e0179169 [PMID: 28586403]
  66. Biofouling. 2011 Oct;27(9):1017-32 [PMID: 22011093]
  67. Clin Microbiol Rev. 1999 Jan;12(1):147-79 [PMID: 9880479]
  68. Open Microbiol J. 2013;7:59-71 [PMID: 23569469]
  69. PLoS One. 2012;7(5):e36659 [PMID: 22606280]
  70. Sci Rep. 2024 Feb 1;14(1):2742 [PMID: 38302495]
  71. Antibiotics (Basel). 2022 Apr 13;11(4): [PMID: 35453271]
  72. Front Microbiol. 2018 Nov 19;9:2664 [PMID: 30510541]
  73. Antimicrob Agents Chemother. 2004 Mar;48(3):909-17 [PMID: 14982783]
  74. J Antimicrob Chemother. 2012 Nov;67(11):2547-59 [PMID: 22833635]
  75. Curr Protoc Microbiol. 2005 Jul;Chapter 1:Unit 1B.1 [PMID: 18770545]

Grants

  1. 124020500028-4/State assignment
  2. ��-26/542/Municipal contract

MeSH Term

Chlorhexidine
Pseudomonas aeruginosa
Staphylococcus aureus
Klebsiella pneumoniae
Escherichia coli
Disinfectants
Microbial Sensitivity Tests
Humans
Membrane Transport Proteins
Cross Infection
Bacterial Proteins
Anti-Bacterial Agents
Benzalkonium Compounds
Drug Resistance, Bacterial

Chemicals

Chlorhexidine
Disinfectants
Membrane Transport Proteins
Bacterial Proteins
Anti-Bacterial Agents
Benzalkonium Compounds

Word Cloud

Created with Highcharts 10.0.00CHXresistanceeffluxS7pumpgenesbiocidesobservednosocomialchlorhexidinesolutionBACprevalencebacteriastrainsbactericidaleffectminprevalentwidespreadusedisinfectantsantisepticsledemergencepathogenslesssensitiveagentscombinationmultidrugMDRcanposesignificantepidemiologicriskinvestigatedsusceptibility05%biocidalcompositebased07%benzalkoniumchloride055%associatedbiociderelationshipantibioticalsodeterminedeffectiveGram-positiveGram-negativeresistantmainlykilled0016%0000084%/00000066%1030amongoftendetectedhighlightspotentialproblemwherebysensitivitydeclinerapidlyfutureNosocomial:SensitivityChlorhexidine-BasedBiocidesPrevalenceEffluxPumpGenesEscherichiacoliKlebsiellapneumoniaePseudomonasaeruginosaStaphylococcusaureusantimicrobialbiofilmformationpumpsquaternaryammoniumcompounds

Similar Articles

Cited By

No available data.